Key Financial Data Of Reporting Company

BrightPath Biotherapeutics Co., Ltd. - Filing #7356865

Concept As at
2023-12-31
2023-10-01 to
2023-12-31
2023-04-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2022-12-31
As at
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
67,000 JPY
5,280,000 JPY
5,229,000 JPY
Ordinary profit (loss)
-947,580,000 JPY
-1,473,774,000 JPY
-1,223,957,000 JPY
Profit (loss)
-953,765,000 JPY
-1,485,633,000 JPY
-1,225,382,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
439,412,000 JPY
362,185,000 JPY
362,025,000 JPY
Total number of issued shares
64,841,300 xbrli:shares
62,891,200 xbrli:shares
62,888,000 xbrli:shares
Net assets
772,753,000 JPY
1,567,541,000 JPY
1,827,471,000 JPY
Total assets
1,428,572,000 JPY
1,701,444,000 JPY
1,974,925,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-6.32
-15.14
-24.90
-20.91
-6.73
Diluted earnings per share
Equity-to-asset ratio
0.524 xbrli:pure
0.909 xbrli:pure
0.915 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.